Eagle Asset Management Inc Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Eagle Asset Management Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$83.14 - $145.99 $26.5 Million - $46.5 Million	-318,354 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$110.08 - $142.92 $1.67 Million - $2.17 Million	-15,162 Reduced 4.55%	318,354 $37.7 Million
Q4 2021 Feb 11, 2022	SELL	$99.73 - $148.48 $194,074 - $288,942	-1,946 Reduced 0.58%	333,516 $46.1 Million
Q3 2021 Nov 10, 2021	SELL	$98.85 - $138.91 $5.36 Million - $7.54 Million	-54,260 Reduced 13.92%	335,462 $46.6 Million
Q2 2021 Aug 11, 2021	SELL	$65.78 - $105.02 $931,444 - $1.49 Million	-14,160 Reduced 3.51%	389,722 $37.8 Million
Q1 2021 May 14, 2021	SELL	$64.07 - $91.75 $9.92 Million - $14.2 Million	-154,904 Reduced 27.72%	403,882 $27.6 Million
Q4 2020 Feb 12, 2021	SELL	$65.07 - $98.24 $6.01 Million - $9.08 Million	-92,379 Reduced 14.19%	558,786 $47.9 Million
Q3 2020 Nov 12, 2020	BUY	$59.04 - $77.95 $377,029 - $497,788	6,386 Added 0.99%	651,165 $41.1 Million
Q2 2020 Aug 12, 2020	SELL	$29.01 - $74.23 $2.81 Million - $7.2 Million	-96,940 Reduced 13.07%	644,779 $44.7 Million
Q1 2020 May 11, 2020	SELL	$27.51 - $57.29 $132,873 - $276,710	-4,830 Reduced 0.65%	741,719 $25.2 Million
Q4 2019 Feb 07, 2020	SELL	$40.86 - $57.65 $9.72 Million - $13.7 Million	-237,786 Reduced 24.16%	746,549 $40.6 Million
Q3 2019 Nov 04, 2019	BUY	$37.38 - $49.47 $36.8 Million - $48.7 Million	984,335 New	984,335 $41.1 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Eagle Asset Management Inc with notifications on news.